Gladyatörler kenti

2018 yks puan ve sıralama hesaplama nasıl yapılır ?

Cumhurbaşkanı Çin’de görüşmelere başladı

SpaceX: Mars’a ilk uçuş 2018’de

Folic Acid May Increase The Risk of Prostate Cancer

English 17 Ekim 2015

 

Folic Acid May Increase The Risk of Prostate Cancer

Prostate cancer is a disease of the small walnut-shaped gland in men which produces seminal fluid that nourishes and transports sperm. It’s one of the most common types of cancer amongst male.

It comes out when cells of the prostate mutate and start to multiply out of control. These cells may spread from the prostate to other parts of the body, especially the bones and lymph nodes. According to the National Cancer Institute, more than 186,000 new cases of prostate cancer were diagnosed last year. Also, 28,660 people died of because of the disease.

While folic acid’s role of anti-carcinogen properties is known, a new study showed high amount of the compound promotes prostate cancer. It’s important in growth and division of cell. This fact explains why too much of this one might cause the growth of cancer and tumors. The researchers at the University of Southern California (USC), claimed that the people who were given a daily folic acid supplement of one mg are more than twice risk of prostate cancer compared with other men who took a placebo. Folic acid is a B vitamin found in many vegetables, beans, fruits and whole grains. It was found to promote the risk of prostate cancer by 163 %.

Jan Figueiredo, an assistant professor at the USC said that “What we think is that perhaps too much folate is not necessarily beneficial, whereas adequate levels may be.” In fact there were too few people having prostate cancers among the study participants to prove that folic acid increases prostate cancer. In addition, having folic acid naturally by foods does not cause the same prostate cancer risk. All these findings show that this compound has a complex role and the disease is not known much. Therefore, more and more studies should be done about this subject.

Yorumlar

Henüz hiç yorum yapılmamış.

Time limit is exhausted. Please reload CAPTCHA.